Citius Pharmaceuticals Inc. - Aset Bersih saben Siji Saham CTXR

Citius Pharmaceuticals (CTXR) minimizes risks through a diversified portfolio of oncology and critical care medications. The book value per common share on this GURU.Markets chart clearly demonstrates the net asset base, where the value 2.42 shows the current figure. The strategy relies on partnerships with medical centers for lymphoma therapy and the stable operation of contract manufacturing capacities.

CTXR - Nilai Buku Siji Saham Citius Pharma ing rentang 04.07.2022 - 27.10.2026

Ringkesan rincian data analitis Citius Pharmaceuticals Inc. (CTXR)

- rega lan prakiraan konsensus rega:

Kutipan saham Citius Pharma|CTXR - Prakiraan gabungan firma investasi

- data kapitalisasi pasar:

Nilai pasar Citius Pharmaceuticals, Inc.|CTXR - Nilai Dipunlarasaken Utang lan Kas

- data kapitalisasi buku:

Nilai Buku saben Saham Citius Pharmaceuticals|CTXR - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku citiuspharma.com|CTXR - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas Citius Pharmaceuticals|CTXR - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Citius Pharma|CTXR - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Citius Pharmaceuticals, Inc.

Pambiji fundamental perusahaan:CTXR citiuspharma.com

Produk asil prodhuksi Citius Pharmaceuticals Inc.

Citius Pharmaceuticals (CTXR) investments in laboratory greening and energy efficiency directly impact the asset structure, determining the final book value per share. This indicator is calculated as the difference between all company assets and liabilities divided by the number of shares, allowing investors to assess the real value of their ownership stake in the event of liquidation.

Pesaing Citius Pharmaceuticals (CTXR)